Makary: EHRs Could Be Used For Patient Matching, Faster Approvals

By Luke Zarzecki / June 17, 2025 at 4:47 PM

FDA Commissioner Marty Makary touted the benefits of using electronic health records (EHRs) for both premarket research and postmarket surveillance, saying at a conference Monday (June 17) the records could be used for patient matching and to immediately monitor drugs when they hit the market, potentially allowing for faster approvals with lower initial evidence thresholds.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.